Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Randomised, double-blind, placebo-controlled study of pivagabine in neurasthenia.

Pizzolato G, Cagnin A, Mancia D, Caffarra P, Avanzi S, Copelli S, Ciappina C, Lo Presti F, Spilimbergo PG, D'Antonio E, Di Costanzo E, Matrango M, Pastres P, Urbani PP, Signorino M, Simoncelli M, Provinciali L, Regnicolo L, Albano C, Roccatagliata G, Rubino V, Cultrera S, Fracassi M.

Arzneimittelforschung. 1997 Nov;47(11A):1329-31.

PMID:
9450159
2.

Role of pivagabine in the treatment of climacteric syndrome.

Gigliotti B, Multinu A, Lai VR.

Arzneimittelforschung. 1997 Nov;47(11A):1317-21.

PMID:
9450156
3.

Evaluation of the efficacy of pivagabine on insomnia associated with mood disorders.

Negri L.

Arzneimittelforschung. 1997 Nov;47(11A):1322-5.

PMID:
9450157
4.

Use of pivagabine in the management of hospitalization distress in children.

Gelsomini S.

Arzneimittelforschung. 1997 Nov;47(11A):1332-5.

PMID:
9450160
5.

Clinical evaluation of the efficacy of pivagabine in the treatment of mood and adjustment disorders.

Terranova R, Gilotta SM, Luca S.

Arzneimittelforschung. 1997 Nov;47(11A):1325-8.

PMID:
9450158
6.

A randomized, double-blind and placebo-controlled study of a Ganoderma lucidum polysaccharide extract in neurasthenia.

Tang W, Gao Y, Chen G, Gao H, Dai X, Ye J, Chan E, Huang M, Zhou S.

J Med Food. 2005 Spring;8(1):53-8.

PMID:
15857210
7.

Pivagabine: a novel psychoactive drug.

Esposito G, Luparini MR.

Arzneimittelforschung. 1997 Nov;47(11A):1306-9. Review.

PMID:
9450153
8.

Effect of pivagabine on stress-induced gastric ulcer formation in rats.

Gianni AM, Bruno G, Sirtori C.

Arzneimittelforschung. 1997 Nov;47(11A):1315-7.

PMID:
9450155
10.

Effects of pivagabine on psychophysical performance and behavioural response in experimental models of stress.

Scapagnini U, Matera M.

Arzneimittelforschung. 1997 Nov;47(11A):1310-4.

PMID:
9450154
11.

Duloxetine efficacy for major depressive disorder in male vs. female patients: data from 7 randomized, double-blind, placebo-controlled trials.

Kornstein SG, Wohlreich MM, Mallinckrodt CH, Watkin JG, Stewart DE.

J Clin Psychiatry. 2006 May;67(5):761-70.

PMID:
16841626
12.

Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.

Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.

Eur Neuropsychopharmacol. 2004 Dec;14(6):457-70.

PMID:
15589385
14.

A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder.

Hollander E, Koran LM, Goodman WK, Greist JH, Ninan PT, Yang H, Li D, Barbato LM.

J Clin Psychiatry. 2003 Jun;64(6):640-7.

PMID:
12823077
15.
16.

A multicenter evaluation of the efficacy and safety of 150 and 300 mg/d sustained-release bupropion tablets versus placebo in depressed outpatients.

Reimherr FW, Cunningham LA, Batey SR, Johnston JA, Ascher JA.

Clin Ther. 1998 May-Jun;20(3):505-16.

PMID:
9663366
17.
18.

Placebo-controlled, multicenter study of sertraline treatment for obsessive-compulsive disorder.

Kronig MH, Apter J, Asnis G, Bystritsky A, Curtis G, Ferguson J, Landbloom R, Munjack D, Riesenberg R, Robinson D, Roy-Byrne P, Phillips K, Du Pont IJ.

J Clin Psychopharmacol. 1999 Apr;19(2):172-6.

PMID:
10211919
19.

N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial.

Berk M, Copolov D, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Judd F, Katz F, Katz P, Ording-Jespersen S, Little J, Conus P, Cuenod M, Do KQ, Bush AI.

Biol Psychiatry. 2008 Sep 1;64(5):361-8. doi: 10.1016/j.biopsych.2008.03.004. Epub 2008 Apr 23.

PMID:
18436195
20.

Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression.

Ravindran AV, Guelfi JD, Lane RM, Cassano GB.

J Clin Psychiatry. 2000 Nov;61(11):821-7.

PMID:
11105734

Supplemental Content

Support Center